Hill March 4, 2024
All of the manufacturers whose drugs were chosen for the federal government’s Medicare price negotiation program have sent back counteroffers for what they consider to be a maximum fair price, the White House said Monday.
President Biden confirmed in a statement Monday that all companies are continuing to engage in the negotiation process, despite the host of legal battles to block the program.
On Feb. 1, the Centers for Medicare and Medicaid Services (CMS) sent out initial offers of a maximum fair price for the first 10 drugs chosen for Medicare negotiations. These include medications of Eliquis, Jardiance, Xarelto, Januvia and Farxiga. Drugmakers had until March 2 to send back counteroffers.
“Today, my Administration is announcing that manufacturers for all...
Today's Sponsors
Today's Sponsor